Download FREE Report Sample
Download Free sampleGonadotropin-releasing Hormone is a?releasing hormone?responsible for the release of?follicle-stimulating hormone?(FSH) and?luteinizing hormone?(LH) from the?anterior pituitary.?
Gonadotropin-releasing Hormone Agonist Drugs Market contains market size and forecasts of Gonadotropin-releasing Hormone Agonist Drugs in global, including the following market information:
Global Gonadotropin-releasing Hormone Agonist Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gonadotropin-releasing Hormone Agonist Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gonadotropin-releasing Hormone Agonist Drugs companies in 2021 (%)
The global Gonadotropin-releasing Hormone Agonist Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Leuprorelin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gonadotropin-releasing Hormone Agonist Drugs include AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Takeda, LIVZON, Ipsen, Sanofi and Endo. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Gonadotropin-releasing Hormone Agonist Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gonadotropin-releasing Hormone Agonist Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gonadotropin-releasing Hormone Agonist Drugs Market Segment Percentages, by Type, 2021 (%)
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
Global Gonadotropin-releasing Hormone Agonist Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gonadotropin-releasing Hormone Agonist Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Other
Global Gonadotropin-releasing Hormone Agonist Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gonadotropin-releasing Hormone Agonist Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gonadotropin-releasing Hormone Agonist Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gonadotropin-releasing Hormone Agonist Drugs revenues share in global market, 2021 (%)
Key companies Gonadotropin-releasing Hormone Agonist Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gonadotropin-releasing Hormone Agonist Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen
Sanofi
Endo
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
